A carregar...
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells
<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer remains the deadliest of all cancers, with a mortality rate of 91%. Gemcitabine is considered the gold chemotherapeutic standard, but only marginally improves life-span due to its chemical instability and low cell p...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2012-09-01
|
| Colecção: | BMC Cancer |
| Assuntos: | |
| Acesso em linha: | http://www.biomedcentral.com/1471-2407/12/419 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|